drugset / Trial / NCT00115141
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Non-randomizedSingle-groupSingle-blindTreatment
Summary
The primary purpose of this study is to evaluate the effectiveness in adults, of four different strengths of resiquimod gel applied to common wart(s) three times a week for four weeks. A second purpose is to evaluate the safety of the drug.
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resiquimod | Small molecule | — | Topical |